NEW YORK (GenomeWeb) – Myriad Genetics said yesterday that it has completed its acquisition of mental health-focused pharmacogenetics firm Assurex Health.

Last month, Myriad announced that it agreed to buy Assurex for $225 million in upfront payments, plus up to $185 million in performance-based milestones. Myriad said that it entered into a $200 million credit agreement with JP Morgan Chase Bank to fund the acquisition.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.